Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000902664-25-000772·HIGHBRIDGE CAPITAL MANAGEMENT LLC
Schedule 13G ownership disclosure
OnKure Therapeutics, Inc.
Class A Common Stock, par value $0.0001 per share · CUSIP: 68277Q105
Event date: 2024-12-31
- Filing-level shares
- 399,743.00
- Percent of class
- 3.2%
- Highbridge Capital Management, LLC
Shares: 399,743.00 · Class: 3.2%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902664-25-000772
- Form type
- SCHEDULE 13G/A
- Filer
- HIGHBRIDGE CAPITAL MANAGEMENT LLC
- CIK
- CIK 919185
- Filed
- Feb 07, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership